ArticleiScience2026

IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft model.

Ryuta Sobu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.